col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

265 Results       Page 1

American Chemical Society: C&EN Global Enterprise
  original article Date Title Authors   All Authors
1 [GO] 2023―Apr―27 Sterling targets low-cost COVID-19 therapy Rick Mullin
2 [GO] 2023―Apr―27 FDA approves the Pfizer-BioNTech COVID-19 vaccine Megha Satyanarayana
3 [GO] 2023―Apr―27 COVID-19: What you need to know about SARS-CoV-2 variants Laura Howes
4 [GO] 2023―Apr―27 Over-the-counter COVID-19 tests make big promises. Do they deliver? Megha Satyanarayana
5 [GO] 2023―Apr―27 Pills to end the pandemic Bethany Halford
6 [GO] 2023―Apr―27 How ACS is emerging from COVID-19 restrictions and planning for the future Paul W. Jagodzinski, chair, ACS Board of Directors
7 [GO] 2023―Apr―27 AstraZeneca’s COVID-19 vaccine related woes grow Megha Satyanarayana
8 [GO] 2023―Apr―27 X-ray screening finds potential COVID-19 drugs Laura Howes
9 [GO] 2023―Apr―27 Merck to allow others to make COVID-19 pill Ryan Cross
10 [GO] 2023―Apr―27 How pregnancy affects COVID-19 vaccine response Laura Howes
11 [GO] 2023―Apr―27 EPA approves PPG’s COVID-19-killing paint Craig Bettenhausen
12 [GO] 2023―Apr―27 COVID-19 test used in UK mass-screening program receives rebuke from FDA Mark Peplow, special to C&EN
13 [GO] 2023―Apr―27 Keeping up with the coronavirus Laura Howes
14 [GO] 2023―Apr―27 Pfizer unveils its oral SARS-CoV-2 inhibitor Bethany Halford
15 [GO] 2023―Apr―26 COVID-19 clean is the new clean Craig Bettenhausen
16 [GO] 2023―Apr―26 Podcast: Jose-Luis Jimenez and Kimberly Prather on COVID-19 transmission and lessons for science communication Jyllian Kemsley
17 [GO] 2023―Apr―26 COVID-19 missteps revealed in 2021 Sam Lemonick
18 [GO] 2023―Apr―26 A strong and stable IP system incentivizes tools to combat COVID-19 Carlyn Burton, chair, ACS Committee on Patents and Related M
19 [GO] 2023―Apr―26 Women published less during early COVID-19 Andrea Widener
20 [GO] 2023―Apr―26 Atea’s COVID-19 drug fails in Phase 2 trials Megha Satyanarayana
21 [GO] 2023―Apr―26 mRNA COVID-19 vaccines by the numbers
22 [GO] 2023―Apr―26 Sanofi ditches mRNA vaccine for COVID-19 Ryan Cross
23 [GO] 2023―Apr―26 Merck drug blocks COVID-19 variants Megha Satyanarayana
24 [GO] 2023―Apr―26 Two COVID-19 antiviral pills advance to late-stage trials Megha Satyanarayana
25 [GO] 2023―Apr―26 The global mass of SARS-CoV-2 Laura Howes
26 [GO] 2023―Apr―26 4′-Fluorouridine fights SARS-CoV-2 in ferrets Bethany Halford
27 [GO] 2023―Apr―26 Looking at my ACS presidential year through the eyes of a pandemic Luis A Echegoyen, ACS immediate past president
28 [GO] 2023―Apr―25 To conquer COVID-19, create the perfect pill Bethany Halford
29 [GO] 2023―Apr―25 What computational scientists learned from COVID-19 Sam Lemonick
30 [GO] 2023―Apr―25 Air pollution disparities persisted during COVID-19 lockdowns Katherine Bourzac
31 [GO] 2023―Apr―25 CureVac stops work on COVID-19 vaccine Megha Satyanarayana
32 [GO] 2023―Apr―25 Sniffing out COVID-19 Carrie Arnold, special to C&EN
33 [GO] 2023―Apr―25 Third COVID-19 antibody is authorized Ryan Cross
34 [GO] 2023―Apr―25 Stopping COVID-19 where it starts Ryan Cross
35 [GO] 2023―Apr―25 Reemerging after COVID-19 Brought to you by ACS Careers
36 [GO] 2023―Apr―25 The antivirals that weren’t: Drug repurposing for COVID-19 produced misleading results Leigh Krietsch Boerner
37 [GO] 2023―Apr―25 Coronaviruses caused epidemics for millennia Laura Howes
38 [GO] 2023―Apr―25 Transistor detects SARS-CoV-2 in less than a minute Mark Peplow, special to C&EN
39 [GO] 2023―Apr―20 Pfizer to license COVID-19 antiviral Michael McCoy
40 [GO] 2023―Apr―19 Antibody drugs may prevent COVID-19 Megha Satyanarayana
41 [GO] 2022―Oct―17 Debate flares up on COVID-19 product IP Shi En Kim
42 [GO] 2022―Sep―12 The challenge of sustainable development in the era of COVID-19 Matt Fisher, Chair, ACS Committee on Science
43 [GO] 2022―Sep―12 China approves the first inhalable COVID-19 vaccine Shi En Kim
44 [GO] 2022―Sep―02 Moderna sues Pfizer and BioNTech over COVID-19 vaccine Gina Vitale
45 [GO] 2022―Jul―25 Paper strip detects SARS-CoV-2 variants Mark Peplow, special to C&EN
46 [GO] 2022―Jul―18 SARS-CoV-2’s survival in air depends on relative humidity Krystal Vasquez
47 [GO] 2022―Jun―06 Peptide from SARS-CoV-2 spike protein forms amyloids Celia Henry Arnaud
48 [GO] 2022―Mar―29 The next generation of COVID-19 antivirals Jared Whitlock, special to C&EN
49 [GO] 2022―Jan―31 Pittcon 2022 is canceled due to COVID-19 Craig Bettenhausen
50 [GO] 2021―Apr―05 Coffee pod COVID-19 test Laura Howes
51 [GO] 2021―Mar―29 AstraZeneca’s COVID-19 vaccine woes mount Ryan Cross
52 [GO] 2021―Mar―22 Women’s careers hurt more by COVID-19 pandemic than men’s Andrea Widener
53 [GO] 2021―Mar―22 Leprosy drug fights SARS-CoV-2 Bethany Halford
54 [GO] 2021―Mar―22 Petrochemicals to slump after the pandemic Alex Tullo
55 [GO] 2021―Mar―22 Undergrads hit hard by pandemic navigate disruptions Michele Solis, special to C&EN
56 [GO] 2021―Mar―15 FDA authorizes COVID-19 diagnostic that uses immune cells Megha Satyanarayana
57 [GO] 2021―Mar―15 Clearing the air of SARS-CoV-2 Mark Peplow, special to C&EN
58 [GO] 2021―Mar―15 CEPI has $3.5 billion plan to stop pandemics Ryan Cross
59 [GO] 2021―Mar―08 Pandemic emission reductions didn’t budge climate Katherine Bourzac
60 [GO] 2021―Mar―01 FDA outlines how to adapt COVID-19 vaccines to virus variants Asher Mullard, special to C&EN
61 [GO] 2021―Feb―22 Lipids for COVID-19 vaccines get investment Michael McCoy
62 [GO] 2021―Feb―02 Plitidepsin could fight COVID-19 Bethany Halford
63 [GO] 2021―Feb―02 Lilly antibody combo reduces COVID-19 deaths Megha Satyanarayana
64 [GO] 2021―Feb―02 What US chemists made before the COVID-19 pandemic Andrea Widener
65 [GO] 2021―Feb―02 How the pandemic changed the industrial chemistry workplace Chemjobber, special to C&EN
66 [GO] 2021―Jan―25 Surface swabbing could predict COVID-19 cases Mark Peplow, special to C&EN
67 [GO] 2021―Jan―25 How COVID-19 has changed the culture of science Bethany Halford
68 [GO] 2021―Jan―25 COVID-19: Science’s greatest test Lisa M. Jarvis
69 [GO] 2021―Jan―25 8 tools that helped us tackle the coronavirus Ryan Cross
70 [GO] 2021―Jan―25 Will public trust in science survive the pandemic? Ryan Cross
71 [GO] 2021―Jan―14 Pandemic stress: The toll it’s taking on students Wynne Parry, special to C&EN
72 [GO] 2021―Jan―04 US funds potential Merck COVID-19 drug Ryan Cross
73 [GO] 2021―Jan―04 Moderna’s COVID-19 vaccine to roll out across the US Ryan Cross
74 [GO] 2020―Dec―18 UK’s COVID-19 mass-screening program under fire Mark Peplow, special to C&EN
75 [GO] 2020―Dec―18 Pfizer COVID-19 vaccine rolls out across the US Ryan Cross
76 [GO] 2020―Dec―18 Coronavirus research dominated Laura Howes
77 [GO] 2020―Dec―09 The UK RECOVERY trial: An ambitious test of COVID-19 treatments Megha Satyanarayana
78 [GO] 2020―Dec―09 Biotech start-ups launched in spite of the pandemic Ryan Cross
79 [GO] 2020―Nov―30 A paint to kill COVID-19 Craig Bettenhausen
80 [GO] 2020―Nov―30 Merck makes third COVID-19 acquisition Megha Satyanarayana
81 [GO] 2020―Nov―30 Wacker to produce COVID-19 vaccine Alex Scott
82 [GO] 2020―Nov―23 Combined COVID-19 and flu tests could help overwhelmed hospitals Megha Satyanarayana
83 [GO] 2020―Nov―23 FDA grants EUA to at-home COVID-19 test Megha Satyanarayana
84 [GO] 2020―Nov―23 Moderna says COVID-19 vaccine is 94.5% effective in preliminary analysis Ryan Cross
85 [GO] 2020―Nov―23 CO2 could be bottleneck in COVID-19 vaccine rollout Craig Bettenhausen
86 [GO] 2020―Nov―23 Following SARS-CoV-2 down the drain Celia Henry Arnaud
87 [GO] 2020―Nov―23 SARS-CoV-2 envelope protein structure solved Laura Howes
88 [GO] 2020―Nov―23 Amid pandemic, chemical firms invest in R&D Michael McCoy
89 [GO] 2020―Nov―16 FDA authorizes COVID-19 antibody therapy Ryan Cross
90 [GO] 2020―Nov―16 Pfizer, BioNTech say their COVID-19 vaccine is successful in late-stage trial Ryan Cross
91 [GO] 2020―Nov―10 Roche taps Atea for COVID-19 antiviral Ryan Cross
92 [GO] 2020―Nov―02 Novartis gets access to COVID-19 therapies Michael McCoy
93 [GO] 2020―Oct―26 Tests alone won’t stop COVID-19 from spreading Megha Satyanarayana
94 [GO] 2020―Oct―26 New opportunities amid the challenges of the pandemic Lee H. Latimer, ACS director-at-large
95 [GO] 2020―Oct―26 Pandemic causes 6-month plunge in CO2 emissions Katherine Bourzac
96 [GO] 2020―Oct―19 Characterizing SARS-CoV-2 antibodies Laura Howes
97 [GO] 2020―Oct―19 How ACS student chapters are adapting to the pandemic Linda Wang
98 [GO] 2020―Oct―12 Small molecule takes aim at SARS-CoV-2 RNA Carolyn Wilke, special to C&EN
99 [GO] 2020―Oct―05 Understanding the COVID-19 bathroom risk Laura Howes
100 [GO] 2020―Oct―05 Biochemistry to boost garlic breath and an update to canine COVID-19 detection Laura Howes
101 [GO] 2020―Oct―05 The tiny tweak behind COVID-19 vaccines Ryan Cross
102 [GO] 2020―Sep―28 Pfizer tests COVID-19 antiviral Bethany Halford
103 [GO] 2020―Sep―28 COVID-19 lockdowns’ strange effects on air pollution Katherine Bourzac
104 [GO] 2020―Sep―28 Impact of COVID-19 on ACS finances William J. Greenlee
105 [GO] 2020―Sep―28 Coronavirus concerns dampen chemists’ economic outlook Andrea Widener
106 [GO] 2020―Sep―28 Glycans on SARS-CoV-2 may help the virus infect cells Alla Katsnelson, special to C&EN
107 [GO] 2020―Sep―21 Lilly antibody shows promise in COVID-19 Lisa M. Jarvis
108 [GO] 2020―Sep―21 Valneva wins UK contract for inactivated coronavirus vaccine Ryan Cross
109 [GO] 2020―Sep―14 Rise in quats observed during coronavirus crisis Laura Howes
110 [GO] 2020―Sep―08 15 min, $5 COVID-19 test rolls out Mark Peplow, special to C&EN
111 [GO] 2020―Sep―08 SARS-CoV-2 has stable genome Laura Howes
112 [GO] 2020―Aug―31 No link between blood type and COVID-19 Alla Katsnelson, special to C&EN
113 [GO] 2020―Aug―31 Saliva tests show promise for widespread COVID-19 surveillance at universities and workplaces Mark Peplow, special to C&EN
114 [GO] 2020―Aug―24 Flavor and fragrance firms dodge pandemic sales blow Michael McCoy
115 [GO] 2020―Aug―17 AI finds alternative routes to COVID-19 drug candidates Mark Peplow, special to C&EN
116 [GO] 2020―Aug―17 The rise of rapid COVID-19 testing Mark Peplow, special to C&EN
117 [GO] 2020―Aug―17 Coronavirus replication structure revealed Celia Henry Arnaud
118 [GO] 2020―Aug―03 CAS COVID-19 data set helps power PerkinElmer dashboard Linda Wang
119 [GO] 2020―Aug―03 First US Phase III trial of a COVID-19 vaccine begins Lisa M. Jarvis
120 [GO] 2020―Aug―03 Fujifilm signs two COVID-19 vaccine pacts Michael McCoy
121 [GO] 2020―Jul―28 Dow plans layoffs as COVID-19 bites earnings Alex Tullo
122 [GO] 2020―Jul―28 COVID-19 is more deadly to men. Probably. Leigh Krietsch Boerner
123 [GO] 2020―Jul―28 COVID-19 vaccines induce immune responses, but questions remain Ryan Cross
124 [GO] 2020―Jul―28 Stinkfrucht in Schweinfurt and sniffer dogs on the scent of SARS-CoV-2 Laura Howes
125 [GO] 2020―Jul―28 How SARS-CoV-2 stops cells producing protein Laura Howes
126 [GO] 2020―Jul―28 Starting a science business during a pandemic Craig Bettenhausen
127 [GO] 2020―Jul―20 Companies preview COVID-19 impact
128 [GO] 2020―Jul―20 What will it take to make an effective vaccine for COVID-19?
129 [GO] 2020―Jul―20 Adagio to make coronavirus antibodies
130 [GO] 2020―Jul―20 How ACS programs are adapting to the pandemic
131 [GO] 2020―Jul―20 Pandemic delays big US chemical projects
132 [GO] 2020―Jul―15 Developing nations face COVID-19 diagnostic challenges
133 [GO] 2020―Jul―15 US preorders COVID-19 vaccine and antibody therapy
134 [GO] 2020―Jul―06 Accuracy of COVID-19 antibody tests questioned
135 [GO] 2020―Jul―06 COVID-19 shakes up summer internships
136 [GO] 2020―Jul―06 FDA lays out COVID-19 vaccine requirements
137 [GO] 2020―Jul―06 Solar production is a pandemic bright spot
138 [GO] 2020―Jun―29 Doctors explore a popular heartburn drug for treating COVID-19
139 [GO] 2020―Jun―29 Solvay warns of COVID-19 impact
140 [GO] 2020―Jun―29 Periodic Graphics: A guide to COVID-19 testing
141 [GO] 2020―Jun―29 COVID-19’s toll on environmental monitoring
142 [GO] 2020―Jun―29 Stranded by the pandemic
143 [GO] 2020―Jun―22 Dexamethasone could help in severe COVID-19
144 [GO] 2020―Jun―22 COVID-19 vaccines and antibodies advance even faster than expected
145 [GO] 2020―Jun―22 Plastics during the pandemic
146 [GO] 2020―Jun―15 Blood type tied to COVID-19 risk
147 [GO] 2020―Jun―15 More COVID-19 vaccine manufacturing deals
148 [GO] 2020―Jun―08 Remembering the chemists we’ve lost to COVID-19
149 [GO] 2020―Jun―08 COVID-19 antibody tests raise as many questions as they answer
150 [GO] 2020―Jun―08 COVID-19 antigen test becomes available in the US
151 [GO] 2020―Jun―08 COVID-19 forces cuts at Ingevity
152 [GO] 2020―Jun―08 Ginkgo gets cash for COVID-19 testing
153 [GO] 2020―Jun―08 Funds and deals fly for COVID-19 vaccine production
154 [GO] 2020―Jun―08 Lilly begins first clinical trial of antibody that targets SARS-CoV-2
155 [GO] 2020―Jun―08 Pandemic puts preprints first
156 [GO] 2020―Jun―01 Artemisinin raises hopes and fears amid COVID-19
157 [GO] 2020―Jun―01 Business cards in the time of COVID-19
158 [GO] 2020―Jun―01 First COVID-19 vaccine data is out
159 [GO] 2020―Jun―01 Merck & Co. joins race for COVID-19 vaccines and therapies
160 [GO] 2020―May―25 Rethinking the role of blood pressure drugs in COVID-19
161 [GO] 2020―May―25 An emerging antiviral takes aim at COVID-19
162 [GO] 2020―May―25 Sumitomo funds COVID-19 detector
163 [GO] 2020―May―25 US signs huge COVID-19 drug contract with a start-up
164 [GO] 2020―May―25 How COVID-19 has put accessibility front and center
165 [GO] 2020―May―25 COVID-19 pushes firms to close plants, cut projects
166 [GO] 2020―May―25 Partners seek CRISPR COVID-19 test
167 [GO] 2020―May―25 US backs UK COVID-19 vaccine
168 [GO] 2020―May―25 Moderna provides cursory glance at first COVID-19 vaccine data
169 [GO] 2020―May―25 Can NO treat COVID-19?
170 [GO] 2020―May―25 CDC sidelined in coronavirus briefings
171 [GO] 2020―May―25 CO2 emissions drop by 17% during the pandemic
172 [GO] 2020―May―18 Coatings and COVID-19
173 [GO] 2020―May―18 Getting back to the lab during COVID-19
174 [GO] 2020―May―18 Drug, chemical firms open COVID-19 patents
175 [GO] 2020―May―18 CEPI commits $384 million to Novavax’s COVID-19 vaccine
176 [GO] 2020―May―18 Can adenoviral vectors overcome a checkered past to win the COVID-19 vaccine race?
177 [GO] 2020―May―18 COVID-19’s CO2 impact
178 [GO] 2020―May―18 Faculty open up about mental health under a pandemic
179 [GO] 2020―May―11 Modelers pledge openness to combat COVID-19
180 [GO] 2020―May―11 FDA adjusts course on validating COVID-19 antibody tests
181 [GO] 2020―May―11 ACC seeks lower tariffs to aid COVID-19 fight
182 [GO] 2020―May―11 AAV-based COVID-19 vaccine is planned
183 [GO] 2020―May―11 STEM-ucation in the time of the coronavirus
184 [GO] 2020―May―11 Big pharma’s quiet effort to find new coronavirus antivirals
185 [GO] 2020―May―11 Navigating the coronavirus job crisis
186 [GO] 2020―May―11 Lonza to make Moderna coronavirus vaccine
187 [GO] 2020―May―11 How remdesivir blocks SARS-CoV-2
188 [GO] 2020―May―11 Cell studies follow up on previous SARS-CoV-2 studyCell studies follow up on previous SARS-CoV-2 study
189 [GO] 2020―May―11 Pandemic hits chemical earnings
190 [GO] 2020―May―04 Genomic epidemiology put to the test against COVID-19
191 [GO] 2020―May―04 IL-6 antibody shows no COVID-19 benefit
192 [GO] 2020―May―04 J&J picks partners for COVID-19 vaccine
193 [GO] 2020―May―04 Podcast: Beating a killer coronavirus
194 [GO] 2020―May―04 Scaling up remdesivir amid the coronavirus crisis
195 [GO] 2020―May―04 Coronavirus entry points could explain its spread
196 [GO] 2020―May―04 The race to reveal the new coronavirus’s structure
197 [GO] 2020―Apr―27 Lending a machine to combat COVID-19
198 [GO] 2020―Apr―27 Antimalarial drugs put to the test for COVID-19
199 [GO] 2020―Apr―27 Ease COVID-19 border controls, say EU CEOs
200 [GO] 2020―Apr―27 NIH consortium to tackle COVID-19 research
201 [GO] 2020―Apr―27 Adding the missing sugars to coronavirus protein structures
202 [GO] 2020―Apr―20 Lilly to test baricitinib against COVID-19
203 [GO] 2020―Apr―20 Computers against COVID-19
204 [GO] 2020―Apr―20 COVID-19 puts damper on chemical deals
205 [GO] 2020―Apr―20 Fujifilm tests favipiravir as COVID-19 treatment
206 [GO] 2020―Apr―20 Merck KGaA helps scale COVID-19 vaccine
207 [GO] 2020―Apr―20 COVID-19 vaccines move toward clinic
208 [GO] 2020―Apr―20 Vir taps Samsung for coronavirus candidate
209 [GO] 2020―Apr―20 Another coronavirus drug target imaged
210 [GO] 2020―Apr―20 Novel coronavirus found in sewage
211 [GO] 2020―Apr―20 What we know about the novel coronavirus’s proteins
212 [GO] 2020―Apr―20 How susceptible is your pet to the novel coronavirus?
213 [GO] 2020―Apr―20 Yeasty treats to get you through the pandemic
214 [GO] 2020―Apr―13 Ruxolitinib to be tested in fight against COVID-19
215 [GO] 2020―Apr―13 Carbon rolls out 3-D printing for COVID-19
216 [GO] 2020―Apr―13 States roll back bag bans for COVID-19
217 [GO] 2020―Apr―13 Nova slows projects because of COVID-19
218 [GO] 2020―Apr―13 Amgen pursues COVID-19 antibodies
219 [GO] 2020―Apr―13 GSK strikes COVID-19 partnerships
220 [GO] 2020―Apr―13 Companies are racing to develop COVID-19 tests for the US. Will the tests help?
221 [GO] 2020―Apr―13 Searching for a coronavirus cure in the blood
222 [GO] 2020―Apr―13 Will the coronavirus help mRNA and DNA vaccines prove their worth?
223 [GO] 2020―Apr―13 How a SARS antibody binds to SARS-CoV-2
224 [GO] 2020―Apr―06 Reagents hold up European COVID-19 tests
225 [GO] 2020―Apr―06 COVID-19 to delay clinical trials
226 [GO] 2020―Apr―06 Grad students on COVID-19’s impact
227 [GO] 2020―Apr―06 What could remdesivir data tell us about tackling COVID-19?
228 [GO] 2020―Apr―06 How ACS is adapting to the coronavirus pandemic
229 [GO] 2020―Apr―06 Faculty cope with coronavirus shutdowns
230 [GO] 2020―Apr―06 Coronavirus starts to weigh on industry
231 [GO] 2020―Apr―06 J&J, BARDA advance coronavirus vaccine
232 [GO] 2020―Apr―06 Did pangolins help spread SARS-CoV-2?
233 [GO] 2020―Apr―03 Emory drug licensed for COVID-19
234 [GO] 2020―Apr―03 Protein mapping points to 69 potential COVID-19 treatments
235 [GO] 2020―Apr―03 Tips for teaching in the time of the coronavirus
236 [GO] 2020―Apr―03 Material shortages hamper testing for novel coronavirus
237 [GO] 2020―Apr―03 T-cell therapies aimed at novel coronavirus
238 [GO] 2020―Apr―03 3-D printing firms rise to coronavirus challenge
239 [GO] 2020―Apr―03 US government allows funding flexibility during coronavirus outbreak
240 [GO] 2020―Apr―03 Targeting a coronavirus protease
241 [GO] 2020―Apr―03 Coronavirus puts spotlight on chloroquine
242 [GO] 2020―Apr―03 Professional training in the time of a pandemic
243 [GO] 2020―Mar―23 IL-6 blockers tested against COVID-19
244 [GO] 2020―Mar―23 How we know disinfectants should kill the COVID-19 coronavirus
245 [GO] 2020―Mar―23 COVID-19 coronavirus weighs on economy, chemicals
246 [GO] 2020―Mar―23 Chemistry departments deal with coronavirus closures
247 [GO] 2020―Mar―23 BioNTech joins the coronavirus vaccine race
248 [GO] 2020―Mar―16 US allocates $8.3 billion for coronavirus
249 [GO] 2020―Mar―16 Chemistry in the time of the coronavirus
250 [GO] 2020―Mar―16 Coronavirus hits Europe
251 [GO] 2020―Mar―16 Another novel coronavirus structure solved
252 [GO] 2020―Mar―16 Heavy hitters join for coronavirus treatments
253 [GO] 2020―Mar―09 Pittcon goes ahead despite coronavirus
254 [GO] 2020―Mar―09 Coronavirus cancels chemical events
255 [GO] 2020―Mar―09 CDC’s coronavirus test runs into early problems
256 [GO] 2020―Mar―09 Gilead and Moderna lead on coronavirus treatments
257 [GO] 2020―Feb―24 Diagnosing COVID-19
258 [GO] 2020―Feb―24 Sanofi, BARDA team for coronavirus vaccine
259 [GO] 2020―Feb―24 Structure of novel coronavirus’s spike protein solved
260 [GO] 2020―Feb―17 Biotech start-ups hit by coronavirus work stoppages
261 [GO] 2020―Feb―10 Artificial intelligence finds drugs that could fight the new coronavirus
262 [GO] 2020―Feb―10 China’s chemical industry shadowed by the coronavirus
263 [GO] 2020―Feb―10 Coronavirus puts drug chemical industry on alert
264 [GO] 2020―Feb―10 GSK and CEPI partner on coronavirus vaccine
265 [GO] 2020―Feb―03 Pharma mobilizes to combat the coronavirus

265 Results       Page 1


Last change 2023―Apr―13 19:50:14 UTC

© Daten-Quadrat 2022       Done in 0.014 sec